Tutorial
These icons indicate there is something to be interacted with. Click it when you see it.
Tutorial
These icons indicate there is something to be interacted with. Click it when you see it.
Tutorial
These icons indicate there is something to be interacted with. Click it when you see it.
touchEXPERT OPINIONS
Experts answer questions with in-depth advice on the current clinical landscape and how new therapies and guidance might impact regional clinical practice. Useful tips below will show how to navigate the activity.
Close
Demystifying virology: The link between the HIV life cycle and ART
- Select in the video player controls bar to choose subtitle language. Subtitles available in English, French, German, Spanish.
- Downloads including slides are available for this activity in the Toolkit
Learning Objectives
- Outline the virology of the HIV life cycle and how it is targeted by different antiretroviral therapies
- Summarize the mechanism of action of current available antiretroviral therapies and the rationale for combining them
- Discuss the risk of resistance to currently available antiretrovirals and strategies to monitor and manage resistance
Overview
In this activity, three HIV experts share their insights on the virology of HIV, the rationale for multidrug antiretroviral therapy (ART) regimens, the mechanisms by which ART resistance develops and how to manage it in people living with HIV.
This activity is provided by touchIME.
Target Audience
This activity has been designed to meet the educational needs of primary care physicians, HIV specialists, infectious disease specialists, genitourinary medicine specialists, specialist nurse practitioners and virologists involved in the management of HIV.
Faculty
Prof. Anne-Mieke Vandamme has no interests/relationships or affiliations to disclose in relation to this activity.
Prof. José Arribas discloses: Advisory board or panel fees from Gilead Sciences, Janssen, MSD and ViiV Healthcare. Consultancy fees from AbbVie, Gilead Sciences, Janssen, MSD and ViiV Healthcare. Grants/research support from ViiV Healthcare.
Prof. Antonella Castagna discloses: Advisory board or panel fees from Gilead Sciences, Janssen-Cilag and MSD. Grants/research support from ViiV Healthcare.
Touch Medical Contributors
Adriano Boasso has no financial interests/relationships or affiliations in relation to this activity.
Date of original release: 31 July 2024.
To obtain the CE/CME credit(s) from this activity, please complete this post-activity test.
Claim Credit- Select in the video player controls bar to choose subtitle language. Subtitles available in English, French, German, Spanish.
- Downloads including slides are available for this activity in the Toolkit
You may also be interested in...
REGISTER NOW FOR FREE ACCESS TO
- 1000+ topical and insightful peer-reviewed journal articles
- 100+ hours of bite-sized congress highlights
- 10 major therapy areas packed with the latest scientific advances
- 150+ specialties offering learn-on-the-go medical education
- + Concise email updates and newsletters so you never miss out